Clinical and Market Analysis of NanoBEO: A Public-Worth, Innovative Therapy for Behavioral and Psychological Symptoms of Dementia (BPSD)-Emerging Evidence and Its Implications for a Health Technology Assessment (HTA) and Decision-Making in National Health Systems

• Main Authors: Damiana Scuteri (Author), Daniele Pierobon (Author), Martina Pagliaro (Author), Kengo Hamamura (Author), Takafumi Hayashi (Author), Loris Pignolo (Author), Pierluigi Nicotera (Author), Giacinto Bagetta (Author), Maria Tiziana Corasaniti (Author)
• Format: Book
• Published: MDPI AG, 2024-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: According to scientific literature, some 99% of patients affected by Alzheimer's disease (AD) suffer from behavioral and psychological symptoms of dementia (BPSD), also known as neuropsychiatric symptoms (NPSs). In particular, agitation is one of the most difficult disorders to trea...